← Back to all trials
Recruiting
NCT05745805
Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China
Conditions: COVID-19, Post-COVID-19 Syndrome, Acute COVID-19, Post-Acute COVID-19
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: 1
Enrollment: 600
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
Location: China
Summary
Our main objective is to analyze the development of physical impact, mental health and blood profile over follow-up time during the 1st wave of the COVID-19.
Besides, we aim to establish a database of post-COVID-19 based on simultaneous cortico-spinal magnetic resonance imaging data to identify high-risk patients with long COVID and prevent the neurological symptoms evolution, optimize the tactics of management in China.
Eligibility Criteria
Inclusion Criteria:Confirmed diagnosis of mild Covid-19 (WHO criteria)/Confirmed diagnosis of moderate Covid-19 (WHO criteria)/Healthy people who have not had COVID-19Exclusion Criteria:History of central nervous system diseases, such as mental disorder, degenerative diseases of central nervous system, tumors, trauma, etc. Participants with indication for MRI studies
Source: ClinicalTrials.gov (NCT05745805). StuddyBuddy aggregates publicly available trial information.
